Synapse Dental

Synapse Dental manufactures the Dental Pain Eraser, an FDA-cleared electronic dental anesthesia device that uses patent-pending Advanced Pulsewave Technology to deliver electrical neuromodulation for pain relief and anxiety reduction in dental procedures. The device eliminates the need for traditional needle anesthesia in many applications, including general dentistry, orthodontics, pediatric dentistry, oral surgery, and endodontic therapy. The Dental Pain Eraser delivers topical pain relief in seconds before patients enter the operatory chair and can be used throughout treatment. The company reports clinical validation through peer-reviewed publications in the Journal of Clinical Orthodontics, Lasers in Medical Science, International Journal of Paediatric Dentistry, and others. The device has received multiple industry awards including three consecutive American Association of Orthodontists (AAO) New Products Showcase Awards (2025, 2024) and the 2023 Ortho Innovator Award. Recent product innovations include the Delta Rail tip for enhanced anesthesia delivery in invasive procedures. The company markets the device to dental practices as a practice differentiator that improves patient experience, increases treatment acceptance rates, and enhances operational efficiency. FDA clearance and clinical evidence support use across multiple dental disciplines for pain management and anxiety reduction.